{"id":"NCT02157935","sponsor":"AstraZeneca","briefTitle":"Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease","officialTitle":"A Phase IIIB, 6-Month, Double-blind, Double-dummy, Randomized, Parallel-group, Multicenter Exacerbation Study of Symbicort® Pressurized Metered-Dose Inhaler (pMDI) 160/4.5 μg x 2 Actuations Twice-daily Compared to Formoterol Turbuhaler 4.5 μg x 2 Inhalations Twice-daily in Cronic Obstructive Pulmonary Disease (COPD) Patients.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-06-27","primaryCompletion":"2016-02-08","completion":"2016-02-08","firstPosted":"2014-06-06","resultsPosted":"2017-06-12","lastUpdate":"2017-11-07"},"enrollment":2026,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["COPD Patients"],"interventions":[{"type":"DRUG","name":"Symbicort","otherNames":[]},{"type":"DRUG","name":"Formoterol turbohaler","otherNames":[]},{"type":"OTHER","name":"Placebo for Symbicort pMDI","otherNames":[]},{"type":"OTHER","name":"Placebo for Formoterol Turbohaler","otherNames":[]}],"arms":[{"label":"Symbicort pMDI","type":"ACTIVE_COMPARATOR"},{"label":"Formoterol Turbuhaler","type":"ACTIVE_COMPARATOR"}],"summary":"Comparing the efficacy of Symbicort® pMDI and Formoterol Turbuhaler in reducing exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD).","primaryOutcome":{"measure":"The Rate of Moderate and Severe COPD Exacerbations Defined as: Worsening of ≥2 Major Symptoms or Worsening of 1 Major Symptom Together With ≥1 Minor Symptom for ≥2 Consecutive Days","timeFrame":"Randomization at Week 0 to End of Treatment (EoT) W 26","effectByArm":[{"arm":"Symbicort pMDI","deltaMin":0.85,"sd":null},{"arm":"Formoterol Turbuhaler","deltaMin":1.12,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0059"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":371,"countries":["United States","Argentina","Bulgaria","Chile","Czechia","Germany","Mexico","Poland","Puerto Rico","South Africa","Spain"]},"refs":{"pmids":[],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=2887&filename=Symbicort_RISE_Revised_CSP_3_4_FINAL_Redacted.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":63,"n":613},"commonTop":["Nasopharyngitis","Chronic obstructive pulmonary disease"]}}